Promosyon programı Moleculin Biotech, Inc.
Gelişmiş program
Basit grafik
Şirket hakkında Moleculin Biotech, Inc.
Moleculin Biotech, Inc., a clinical stage pharmaceutical company, focuses on the development of drug candidates for the treatment of cancers and viruses. Its lead drug candidate is Annamycin, which is in Phase 1/2 studies for the treatment of relapsed or refractory acute myeloid leukemia (AML) and cancers metastasized to the lungs. The company's flagship immune/transcription modulator is WP1066 that is in Phase I clinical trial for the treatment of brain tumors and pediatric brain tumors, as well as pancreatic cancer and other malignancies. daha fazla ayrıntı| IPO date | 2016-06-02 |
|---|---|
| ISIN | US60855D2009 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.moleculin.com |
| Цена ао | 1.07 |
| Günlük fiyat değişimi: | -0.9524% (1.05) |
|---|---|
| Haftalık fiyat değişimi: | -4.59% (1.09) |
| Aylık fiyat değişimi: | -17.46% (1.26) |
| 3 ayda fiyat değişimi: | -36.97% (1.65) |
| Altı ayda fiyat değişimi: | -63.38% (2.84) |
| Yıllık fiyat değişimi: | -82.4% (5.91) |
| 3 yılda fiyat değişimi: | -42.22% (1.8) |
| 5 yılda fiyat değişimi: | +24.55% (0.835) |
| Yılbaşından bu yana fiyat değişimi: | -55.17% (2.32) |
|
|
Hafife alma
|
Yeterlik
|
|||||||||||||||||||||||||||||||||||||
Temettüler
|
Görev
|
Büyüme dürtüsü
|
|||||||||||||||||||||||||||||||||||||
| Kurumlar | Hacim | Paylaşmak, % |
|---|---|---|
| Armistice Capital, LLC | 213829 | 9.6 |
| Vanguard Group Inc | 72009 | 3.23 |
| Geode Capital Management, LLC | 16445 | 0.74 |
| Blackrock Inc. | 12595 | 0.57 |
| Renaissance Technologies, LLC | 8640 | 0.39 |
| State Street Corporation | 4760 | 0.21 |
| Citadel Advisors Llc | 4310 | 0.19 |
| Northern Trust Corporation | 3573 | 0.16 |
| Atticus Wealth Management, LLC | 3333 | 0.15 |
| Schmidt (P.J.) Investment Management Inc. | 1933 | 0.09 |
| Süpervizör | İş unvanı | Ödeme | Doğum yılı |
|---|---|---|---|
| Mr. Walter V. Klemp | Co-Founder, Chairman, President & CEO | 894.54k | 1960 (65 yıllar) |
| Mr. Jonathan P. Foster CPA | Executive VP & CFO | 611.17k | 1964 (61 yıl) |
| Dr. Donald H. Picker Ph.D. | Chief Scientific Officer | 486.44k | 1946 (79 yıllar) |
| Dr. Waldemar Priebe Ph.D. | Co-Founder, Founding Scientist & Chairman of Scientific Advisory Board | N/A | |
| Dr. John Paul Waymack M.D., Sc.D. | Senior Chief Medical Officer | N/A | 1952 (73 yıl) |
| Dr. Sandra L. Silberman M.D., Ph.D. | Chief Medical Officer of New Products | N/A | 1955 (70 yıllar) |
| Dr. Wolfram C. M. Dempke M.B.A., M.D., Ph.D. | European Chief Medical Officer | N/A |
Adres: United States, Houston. TX, 5300 Memorial Drive - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.moleculin.com
Web sitesi: https://www.moleculin.com
